Solid Biosciences Inc. SLDB Available For Sale Securities Debt Securities Current
Available For Sale Securities Debt Securities Current at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s available for sale securities debt securities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s available for sale securities debt securities current?
- Solid Biosciences Inc. (SLDB) reported available for sale securities debt securities current of $83.58M in Q1 2026.
- How has Solid Biosciences Inc.'s available for sale securities debt securities current changed year-over-year?
- Solid Biosciences Inc.'s available for sale securities debt securities current decreased by 13.2% year-over-year, from $96.29M to $83.58M.
- What is the long-term trend for Solid Biosciences Inc.'s available for sale securities debt securities current?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s available for sale securities debt securities current has grown at a 9.6% compound annual growth rate (CAGR), from $88.64M to $127.95M.